Claim A Piece of the Great American Health Insurance Highway Robbery: 3 Stocks to Buy

Healthcare has gotten a lot of attention in the last year and a half, thanks to the most significant worldwide pandemic since World War I. Hundreds of thousands of individuals have been hospitalized in the United States as a result of the pandemic. While health insurance covers these costly expenditures, most Americans cannot afford to pay them out of pocket.

The increased demand for healthcare, along with the pandemic-related fears, has resulted in a significant increase in membership registrations. More money appears on the balance sheets of leading health insurance firms as more premiums are paid. When you include in the growing general healthcare demands of the elderly, health insurance stocks appear to be a sound investment.

This was seen in the most recent quarter when health insurance firms outperformed the market. This strong demand for insurance isn’t projected to go away anytime soon, so chosen health insurance businesses still have both short-term and long-term potential to grow.

Let’s take a look at just three health insurance stocks that the experts are calling wise portfolio choices:

Stamsberry Research:

Connecticut Woman Gets “Revenge” After Losing Nearly 50% of Her 401(k)

In a story that’s drawn national attention, a Roxbury, Connecticut woman is seeking “revenge” against Wall Street… And so far – it’s working. [Full Story Here…]

Molina Healthcare Inc (MOH)

MOH provides healthcare programs for limited families and individuals that are Medicaid-related. A network of companies, each of which is certified as a health maintenance organization, manages the company’s health insurance (HMO). In addition to MOH’s Health Plans division, the corporation maintains a Medicaid Solutions division that offers Medicaid management information system solutions to state governments in the US.

MOH‘s revenue increased 40.2% year-over-year in the third quarter, above analyst projections. A rise in membership and increased premium income drove most of that growth. Notably, MOH has either exceeded or met analysts’ expectations for the past three consecutive quarters. Forecasts show annual and quarterly growth for both EPS and revenue. MOH currently shows an EPS of $2.71 per share and $7.1 billion in sales. The consensus price target for MOH among analysts that give 12-month price projections is 330.00, with a high of 397.00 and a low of 275.00. The median estimate reflects an increase of 5.41% over the previous price. The consensus among experts is to buy MOH stock.

Anthem Inc (ANTM)

Brownstone Research:

The Truth Behind the Global Chip Shortage- do not use.

GM and Toyota factories are shutting down… Mass shortages of electronics… Medical device production nearly halted… But what you probably don’t yet realize–what few so far have figured out… Is what’s really causing it. [Full Story Here…]

ANTM is one of the largest private health insurance companies in the United States, with around 44 million medical members. Employer, individual, and government-sponsored coverage plans are all available via the firm. It also operates as the Blue Cross Blue Shield Association’s licensee in 14 states, making it the most significant single Blue Cross Blue Shield branded coverage provider.

ANTM had a solid third quarter, with earnings exceeding expectations and increasing by 61.7%. They have exceeded analysts’ projections on revenue and EPS for two straight quarters. An increase in income from Medicaid and Medicare, as well as premium rate hikes and larger membership, all contributed to the company’s growth. ANTM currently pays an annual dividend yield of 0.99%. Their year-over-year numbers all indicate growth, as do forecasts for yearly and quarterly EPS/Revenue. They now show us an impressive $5.11 per share and $36.5 billion in sales. The median price target for ANTM from analysts that provide 12-month price projections is 469.00, with a high of 559.00 and a low of 429.00. The median estimate implies an increase of 7.96% over the most recent price. ANTM’s buy rating is strong.

UnitedHealth Group Inc (UNH)

UNH is the biggest private health insurance company in the US, with 48 million members served by domestic and foreign operations. The corporation has a significant scale in managed care as a leader in employer-sponsored, self-directed, and government-backed insurance programs. Furthermore, UNH’s investments in its Optum businesses have built a health services behemoth that covers everything from medical and pharmaceutical coverage to outpatient care and analytics.

UNH has easily bested analysts’ projections on EPS and Revenue for the past four consecutive fiscal quarters, and it shows no sign of slowing down. They currently pay a dividend of $1.45, with a yield of 1.3%. Their numbers are just as impressive as their string of earnings successes would indicate for the current quarter. Their EPS comes in at $4.32 per share, and they boast sales of $72.5 billion. The analysts that provide 12-month price projections give UNH a median target of 480.00, with a high of 522.00 and a low of 435.00. This estimate represents a 5.39% increase from its current stock price. The consensus among experts gives UNH the most solid of buy ratings.